TATVA CHINTAN PHARMA IPO GMP TODAY (LIVE DATA) Latest Grey Market Premium Updates

Tatva Chintan Pharma IPO GMP Today, Tatva Chintan IPO Grey Market Premium Updates | Tatva Chintan Pharma IPO Listing Gain, Latest target, Opening gain

Tatva Chintan Pharma Chem Ltd initial public offer (IPO) is set to open for subscription on July 16 and close on July 20, after it received capital market regulator Sebi’s go-ahead to raise Rs 500 crore through public issue.

Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.

Check out Tatva Chintan Pharma IPO grey market premium, Kostak rates, and subject to sauda rates as of today.

Tatva Chintan Pharma IPO Details:

Issuer Tatva Chintan Pharma Chem Ltd
Issue Type Book Built Issue IPO
Issue Period Issue Opens: July 16, 2021
Issue Closes: July 20, 2021
Price Brand ₹1073 to ₹1083 Per Share
Issue Size ₹500 Crores
Face Value Rs. 10 per Equity Share
Market Lot 13 Shares
Maximum Bid amount for Retail Rs. 2 Lakhs
QIB 50% of the issue size
NIB 15% of the issue size
Retail Individual Bidders 35% of the issue size
Fresh Issue ₹ 225 Cr
Offer for Sale ₹ 275 Cr
Listing at NSE & BSE
Apply With Upstox Free DEMAT Account
Equity 4616805 Shares
Grey Market Price Tatva Chintan Pharma IPO GMP Today

UPCOMING IPO IN JULY 2021

Tatva Chintan IPO REVIEW

Tatva Chintan IPO Apply Or Not?

Tatva Chintan IPO GMP

Tatva Chintan Pharma IPO GMP Rates day by day

Tatva Chintan Pharma IPO Grey market premium as on today

Date GMP (in INR) Kostak (in INR) Subject to Sauda
28 July 2021 1140    
27 July 2021 1150    
26 July 2021 1150 400 11000
25 July 2021 1050    
24 July 2021 1020 400 8500
23 July 2021 1010 400 8500
22 July 2021 920 350 8000
21 July 2021 915 350 7500
20 July 2021 790 350 7000
19 July 2021 770 350 7500
18 July 2021 720 300 7000
17 July 2021 700 300 7000
16 July 2021 680 350 7000
15 July 2021 630 300 5500
14 July 2021 600 300 5500
13 July 2021 530 300 5500
12 July 2021 575 250 6000
11 July 2021 600 300 6000
10 July 2021 350    

How to Apply for Tatva Chintan Pharma IPO :

If you’re a new investor Open DEMAT Account for free with Angel Broking and build wealth with the best stock choices. Join 1 million+ family of happy customers.

In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before UPI mandate expiry date. Please reach out to your bank in case funds are not unblocked/released post the mandate expiry date.

Tatva Chintan Pharma IPO Market Lot:

 Lot Size:  Minimum 13 Shares & Maximum 182 Shares
 Minimum Amount:  ₹14070
 Maximum Amount: ₹197106

Tatva Chintan IPO Allotment & Listing:

 Basis of Allotment: July 26, 2021
 Refunds: July 27, 2021
 Credit to Demat Account: July 28, 2021
 Listing Date: July 29, 2021

Check:- Tatva Chintan Pharma IPO Allotment Status

Disclaimer:

– IPO Grey Market Premium (IPO GMP) mention is valid for the specific date as mentioned in the header.
– We are not buying and selling IPO forms on IPO Grey Market.
– Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
– Do not subscribe for IPO by just seeing premium Price as it may change anytime before listing. Subscribe only considering Fundamental of the companies.
– This is only coverage of News related to Grey Market . We don’t deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

IPO GMP rates are provided as sourced from market intelligence. Please note these IPO GMP rates may be different depending on geographies and markets.

We don’t trade into grey market nor do we facilitate buying or selling of IPO forms.

What is Grey Market?

Grey Market is the term used to describe unregulated over-the-counter market for trading IPO applications and IPO shares before the stock is listed at a stock market. This is a way for dealers to support their customers who may want to exit before listing.

This is also a way to boost the listing price and support the issue before listing happens. There are two kinds of transactions that happen in thee IPO grey market:

  • Trade of IPO shares at a grey market premium
  • Trade of IPO application at a kostak.

What is Grey Market Premium?

GMP or Grey Market Premium is the premium at which equity shares from the IPO are being traded in the grey market.

This could either be a positive or negative – meaning the trading price in the grey market is either higher or lower than issue price respectively, based on demand and supply for the shares.

Typically, investors who do not want to take the risk of allocation not happening through IPO will buy shares in the gray market and hope to flip the shares on listing to make a good profit.

What is Kostak?

Kostak is the premium at which IPO application is being traded in the grey market. Applications are typically traded after the application window is closed but the allotment has not yet been finished.

It is rare for someone to trade IPO application post-allocation. This is a way for investors to increase their chance of shares being allotted as the allocation process treats each retail application equally. An example (indicative) for kostak is:

Example:

Tatva Chintan Pharma CHEM Limited
Issue Price: Rs 306 Per Equity Share (Maximum Bid price)
Lot Size: 45
Grey Market Premium: Rs 220 to Rs 230
Kostak (Rs 13770): Rs 680 to Rs 720

This means Tatva Chintan Pharma applications of Rs 13770 are being traded in IPO Grey Market at Rs 680 to Rs 720.

Despite the fact that this IPO’s Grey Market Premium is roughly 75% of the issue price, the ‘Kostak’ is just 5% of the application value.

As can be seen the Kostak is at a much lower %age than GMP. This indicates that the grey market expects the issue to be oversubscribed and expects on an average only one lot to be allocated per application.

Kostak rate is the amount an investor gets by selling his/her IPO application in grey market. This is the amount an investor stands to gain, irrespective of allotment status.

Subject to Sauda simply reflects the amount which an investor stands to get by selling his/her application for firm allotment. The key operative word here is firm allotment. In case of no allotment to the applicant, the sauda stands cancelled.

In case of ‘Subject to Sauda’ deal, while selling IPO application in the grey market, buyer and seller agree that deal is only valid if the seller will get the allotment. If the seller doesn’t get any shares in IPO process, the deal gets avoid.

FAQs

What is the Grey Market Premium (GMP) price of Tatva Chintan Pharma IPO?

The Grey Market Premium of Tatva Chintan Pharma IPO is approx. Rs.530 at the moment.

What is the Subject to Sauda price for Tatva Chintan Pharma IPO?

The Subject to Sauda price for Tatva Chintan Pharma IPO is approx. Rs. 5500/-

How much will be listing gain in Tatva Chintan Pharma IPO?

Tatva Chintan Pharma IPO listing gain will be approx. Rs.6900/- (update on a daily basis)

What is kostak price of Tatva Chintan Pharma IPO?

The Kostak price of Tatva Chintan Pharma IPO is approx. Rs 300/-.

When is Tatva Chintan Pharma IPO listing date?

Tatva Chintan Pharma IPO listing date is Jul 29, 2021.

LEAVE A REPLY

Please enter your comment!
Please enter your name here